Position in QGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,559,467
New position
Shares Held
321,214
first reported quarter
Ownership
0.156%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#66
of 332 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in QGEN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$19,550,000
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026READYSTATE ASSET MANAGEMENT LP holds $20,338,822 across 2 Diagnostics & Research names. QGEN ranks #1 (61.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
This page
|
321,214 | $12,559,467 | |
| 2 | GH |
Guardant Health, Inc.
|
51,852 | $7,779,355 |
All Filings in QGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,550,000 | 500,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $12,559,467 | 321,214 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||